New Gene-Editing and CAR-T Findings Push the Next Wave of Cell Therapy Forward
New Nature findings show durable progress in gene and cell therapy, from hemophilia B gene therapy to long-term CAR-T persistence.
Breakthroughs in gene editing, gene therapy and cell-based treatments for inherited and serious diseases.
UK Medical Research News: New Clinical, Genetic and AI Advances Emerge Across Leading Journals and MRC Updates
Latest UK medical research news covers genetics, AI surgery, vaccination trends and MRC updates shaping patient care.
MRC-backed study brings gene therapy closer to children with rare fatal immune disease
UKRI’s MRC is funding research into fatal genetic diseases, amid a busy run of UK medical science updates.
MRC Launches Fresh Funding Push for Fatal Genetic Disease Research
MRC has announced new funding for fatal genetic disease research, reinforcing UK support for rare disease science.
UK Scientists Uncover New Clues in Fatal Genetic Diseases as MRC Funding Expands
MRC funding is backing UK research into fatal genetic diseases, aiming to reveal disease mechanisms and speed future treatments.
MRC backs world-class research into fatal genetic diseases in new UK funding drive
MRC has announced new funding for fatal genetic disease research, alongside recent UK advances in cancer, obesity and diagnosis.
Gene Editing Shows New Promise for Severe Blood Disorders
Gene editing trials show renewed promise for sickle cell disease and β-thalassemia, with fetal hemoglobin reactivation emerging as a key strategy.
Mayo Clinic Researchers Say Genetic Scoring Could Sharpen Pulmonary Fibrosis Diagnosis
Mayo Clinic says a genetic scoring tool may improve diagnosis and prognosis in idiopathic pulmonary fibrosis.
Genomics-Guided Off-Label Cancer Treatment Shows Modest Results in Large Nature Study
Large Nature study finds genomics-guided off-label cancer treatment shows modest overall results, with benefits in selected patients.
CRISPR Gene Therapy Reduces Signs of Duchenne Muscular Dystrophy in Animal Models, Preclinical Study Shows
Studiu preclinic arată că o terapie bazată pe CRISPR a ameliorat semnele distrofiei musculare Duchenne la modele animale; cercetătorii subliniază necesitatea studiilor suplimentare și evaluării siguranței înainte de aplicarea la om.
